Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
19:23:04 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 145.62 USD | -0.60% |
|
-3.70% | +67.04% |
| Market Cap | 9.48B 8.18B 7.7B 7.02B 13.12B 895B 13.22B 91.2B 35.4B 458B 35.6B 34.82B 1,504B | P/E 2026 * |
31.5x | P/E 2027 * | -309x |
|---|---|---|---|---|---|
| Enterprise Value | 8.94B 7.71B 7.27B 6.62B 12.37B 845B 12.47B 86.02B 33.39B 432B 33.57B 32.84B 1,419B | EV / Sales 2026 * |
16.5x | EV / Sales 2027 * | 44.1x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Protagonist Therapeutics, Inc.
| 1 day | -0.55% | ||
| 1 week | -3.70% | ||
| Current month | -1.26% | ||
| 1 month | +10.29% | ||
| 3 months | +56.48% | ||
| 6 months | +54.81% | ||
| Current year | +67.04% |
| 1 week | 141.95 |  | 151.68 |
| 1 month | 131.68 | | 160.81 |
| Current year | 77 | | 160.81 |
| 1 year | 54.5 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/08/26 | Exercice | Chief Executive Officer | 102,717 | 0.1597% | ||
| 10/06/26 | Exercice | Director | 27,000 | 0.0420% | ||
| 29/05/26 | Exercice | Director | 27,000 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | -3.70% | +147.90% | +645.48% | 9.48B | |
| +0.97% | -0.75% | +3.51% | +17.79% | 49.74B | |
| -0.71% | -3.52% | +425.83% | +516.98% | 44.98B | |
| +2.59% | +1.02% | +43.78% | +19.60% | 42.52B | |
| +0.85% | -3.67% | +9.02% | +76.72% | 40.78B | |
| -0.90% | -1.74% | +15.20% | +48.44% | 32.89B | |
| +1.87% | +6.08% | - | - | 17.09B | |
| +1.47% | -4.95% | +24.31% | +121.95% | 16.28B | |
| +1.70% | -0.05% | +18.53% | +28.09% | 14.4B | |
| +2.44% | -2.25% | +78.89% | +41.20% | 13.48B | |
| Average | +0.92% | -2.45% | +85.22% | +168.47% | 28.16B | |
| Weighted average by Cap. | +0.81% | -2.26% | +95.21% | +146.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 468M 441M 402M 751M 51.23B 756M 5.22B 2.02B 26.19B 2.04B 1.99B 86.03B | 203M 175M 165M 151M 282M 19.22B 284M 1.96B 760M 9.82B 764M 747M 32.27B |
| Net income | 324M 279M 263M 240M 448M 30.58B 451M 3.12B 1.21B 15.64B 1.22B 1.19B 51.37B | -32.12M -27.71M -26.1M -23.78M -44.46M -3.03B -44.79M -309M -120M -1.55B -121M -118M -5.1B |
| Net Debt | -538M -464M -437M -399M -745M -50.85B -751M -5.18B -2.01B -26B -2.02B -1.98B -85.4B | -511M -441M -415M -378M -707M -48.28B -713M -4.92B -1.91B -24.68B -1.92B -1.88B -81.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | US$145.92 | -0.39% | 231,459 |
| 01/09/26 | US$146.49 | -0.85% | 534,144 |
| 31/08/26 | US$147.75 | +2.37% | 567,395 |
| 28/08/26 | US$144.33 | -3.46% | 501,247 |
| 27/08/26 | US$149.50 | -1.32% | 381,590 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
